Leaflet STIRIPENTOL BILLEV 500mg capsules


Indicated for: epilepsy

Substance: stiripentol (antiepileptic)

ATC: N03AX17 (Nervous system | Antiepileptics | Other antiepileptics)

Stiripentol is an antiepileptic medication used as adjunctive therapy for the treatment of Dravet syndrome, a rare form of epilepsy. It works by enhancing the effects of other antiepileptic drugs, such as clobazam and valproate, and by reducing neuronal excitability.

The medication is taken orally, as directed by a doctor, usually two or three times daily. It is important for patients to adhere to the treatment regimen and avoid abrupt discontinuation.

Patients should be aware of potential side effects, such as drowsiness, nausea, or decreased appetite. It is important to inform the doctor of any unusual symptoms.

Common side effects include drowsiness, nausea, and decreased appetite. In rare cases, severe reactions such as neutropenia or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about STIRIPENTOL BILLEV 500mg

  • Substance: stiripentol
  • Date of last drug list: 01-12-2024
  • Commercial code: W70729001
  • Concentration: 500mg
  • Pharmaceutical form: capsules
  • Quantity: 30
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: MISOM LABS LIMITED - MALTA
  • Holder: BILLEV PHARMA APS - DANEMARCA
  • Number: 15688/2024/01
  • Shelf life: 3 years

Pharmaceutical forms available for stiripentol

Concentrations available for stiripentol

  • 250mg
  • 500mg